TRANSACTIONS IN CONNECTION WITH SHARE BUYBACK PROGRAMME

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
TRANSACTIONS IN CONNECTION WITH SHARE BUYBACK PROGRAMME

On 17 February, PANDORA initiated a share buy-back programme, cf. Company announcement no. 217. The programme is implemented in accordance with the provisions of European Commission Regulation no. 2273/2003 of 22 December 2003 (the Safe Harbour Regulation). The purpose of the programme is to reduce PANDORAs share capital and to meet obligations arising from employee share option programmes.

Under the programme PANDORA will buy back shares for an amount up to DKK 3,900 million in the period from 17 February to 31 December 2015.

The following transactions have been made under the programme:

  Number of shares Average purchase price, DKK Transaction value, DKK
Accumulated last announcement 5,344,023   3,863,406,874
7 December 2015 7,000 855.97 5,991,795
8 December 2015 8,000 848.59 6,788,741
9 December 2015 4,000 838.64 3,354,546
10 December 2015 350 823.71 288,300
11 December 2015 8,000 809.37 6,474,937
Accumulated under the program 5,371,373   3,886,305,193

With the transactions stated above, PANDORA owns a total of 6,050,615 treasury shares, corresponding to 4.9% of the share capital.

ABOUT PANDORA PANDORA designs, manufactures and markets hand-finished and contemporary jewellery made from high-quality materials at affordable prices. PANDORA jewellery is sold in more than 90 countries on six continents through approximately 9,500 points of sale, including more than 1,600 concept stores.

Founded in 1982 and headquartered in Copenhagen, Denmark, PANDORA employs more than 15,000 people worldwide of whom approximately 10,400 are located in Gemopolis, Thailand, where the company manufactures its jewellery. PANDORA is publicly listed on the NASDAQ Copenhagen stock exchange in Denmark. In 2014, PANDORA’s total revenue was DKK 11.9 billion (approximately EUR 1.6 billion).

CONTACT For more information, please contact:

INVESTOR RELATIONS                             Morten Eismark                                              VP Group Investor Relations                          Phone +45 3673 8213                                     Mobile +45 3045 6719                                   MEDIA RELATIONS Kristian Lysgaard Director, Group Communications Phone +45 4323 1774 Mobile +45 2556 8561
Magnus Thorstholm Jensen Investor Relations Officer Phone +45 4323 1739 Mobile +45 3050 4402  
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the Future of Dry Type Transformers in Global Markets

Updated Category News Views 130

The Growth of the Dry Type Transformer Market The global dry type transformer market is set to experience substantial growth, projected to rise from an estimated USD 11.72 billion in the near future to USD 16.33 billion by the end of the decade. This growth is fueled by a rising demand for reliable, sustainable, and low-maintenance power distribution solutions across...

Continue Reading
GuideWell's 2024 Impact Report Outlines Health Care Advancements

Updated Category News Views 645

GuideWell Unveils Its 2024 Impact Report Focused on Health Care GuideWell Mutual Holding Corporation recently published its annual Impact Report, shedding light on the organization's significant advancements in health care accessibility and quality. This not-for-profit entity is dedicated to reshaping how health services are delivered while putting its members and...

Continue Reading
Revolution in Automotive Security: Titan's Drone Innovation

Updated Category News Views 169

Enhancing Automotive Security with Drones In a significant advancement for automobile dealerships, Titan Protection and Consulting has successfully implemented its innovative security drone technology. This unprecedented deployment focuses on curbing theft and enhancing surveillance at automotive retail facilities. With the rise of sophisticated security solutions,...

Continue Reading
Atossa Therapeutics Announces Participation in Virtual Summit

Updated Category News Views 74

Atossa Therapeutics to Join the 2024 Maxim Healthcare Summit SEATTLE — Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company committed to developing innovative solutions in oncology, has exciting news to share. The company has announced that Michael Parks, the Vice President of Investor and Public Relations, will take part in a virtual...

Continue Reading
Investors Urged to Act Quickly in Vicor Class Action Lawsuit

Updated Category News Views 80

Investors Advised to Act Swiftly in Vicor Class Action Lawsuit Attention investors! If you've lost over $100,000 in Vicor Corporation shares, now's the time to take action. Kahn Swick & Foti, LLC (KSF), along with managing partner Charles C. Foti, Jr., a former Attorney General of Louisiana, wants to remind you of an important deadline approaching for filing lead...

Continue Reading